02:00PM - 02:07PM
Assessment of liver fibrosis using Fibroscan in patients with NAFLD and Type 2 diabetes mellitus
02:07PM - 02:14PM
Osteopenia in Type 2 Diabetes Versus Non-Diabetic Subjects: A Retrospective Assessment Using Simple Clinical Tools in a Resource-Limited Clinical Setting
02:14PM - 02:21PM
Efficacy of Structured Nutritional Counseling Combined with Pharmacotherapy in Obese Type 2 Diabetes Mellitus: A Retrospective Comparative Observational Study
02:21PM - 02:28PM
Office-based WHO 2019 (BMI) cardiovascular disease (CVD) risk algorithm, offer scalable screening, but its performance may vary across populations. Comparative data between South Asian populations are
02:28PM - 02:35PM
QRISK3 Performance and Coronary Atherosclerotic Burden in Chest Pain Patients: A Comparative Analysis of Diabetic vs Non-Diabetic Cohorts
02:35PM - 02:42PM
Comparative In Vitro Dissolution Assessment of 6 Widely prescribed Tamsulosin (0.4 mg) Modified Release Oral Formulations in India: Implications for diabetic patients with benign prostatic hyperplasia
02:42PM - 02:49PM
Diabetic Neuropathy-Osteopenia Axis: 78% Neuropathy Prevalence with 60-71% Concurrent Bone Loss Across Severity Grades—A Novel Neuro-Skeletal Comorbidity
02:49PM - 02:56PM
Triglyceride-to-HDL Ratio Outperforms Individual Lipid Parameters and HbA1c in Predicting Diabetes Complications: Machine Learning Analysis
02:56PM - 03:03PM
When HbA1c Lies: Hypertriglyceridemia and Obesity Drive Multi-System Complications in ‘Well-Controlled’ Type 2 Diabetes
03:03PM - 03:10PM
Unsupervised Machine Learning Reveals Three Distinct Clinical Phenotypes in Type 2 Diabetes With Differential Complication Burden
03:10PM - 03:17PM
Microvascular and Macrovascular Complications in Young-Onset Type 2 Diabetes Compared with Type 1 Diabetes: A Retrospective Cross-Sectional Study from North India
03:17PM - 03:24PM
Practical Tips for Recognizing and Addressing Insulin Inertia in Primary Care
03:24PM - 03:31PM
Correlation Between Cognitive Impairment and Cardiac Autonomic Dysfunction in Type 2 Diabetes Mellitus
03:31PM - 03:38PM
Dapagliflozin and Body Weight Reduction in Overweight Patients (BMI>24) with T2DM: A Systematic Review
03:38PM - 03:45PM
Comparative concurrent validity of office-based WHO 2019 cardiovascular risk algorithm with laboratory criterions among Gujarati-Indian and Pokhareli-Nepalese adults
03:45PM - 03:52PM
Diagnostic Discordance Between HbA1c and Plasma Glucose in Drug-Naïve Adults: Real-World Evidence from an Indian OPD
03:52PM - 03:59PM
Isolated Elevation of HbA1c with Normoglycaemia in Drug-Naïve Adults: A Real-World OPD Study
03:59PM - 04:06PM
Impact of Pharmacological Therapy on Bone Mineral Density and Muscle Strength in Postmenopausal Women with Type 2 Diabetes
04:06PM - 04:13PM
A Prospective Comparative Study on the Incidence of Hypoglycemia in Patients with Type 2 Diabetes Mellitus Treated with Vildagliptin plus Metformin versus Glibenclamde plus Metformin – SHIELD STUDY
04:13PM - 04:20PM
Urinary Acidification as a Metabolic Footprint of Dysglycemia: Evidence from a Real-World Rural Cohort
04:20PM - 04:27PM
Atypical Presentation of Alagille Syndrome: Early-Onset Diabetes as a Key Clinical Clue
04:27PM - 04:34PM
Automated Insulin Delivery With GLP-1 Agonist Helps Achieve Glycemic Targets With Reduction in Weight and Insulin Dose in Type 2 Diabetes: A Case Report From India
04:34PM - 04:41PM
Glycosuria as a Harbinger of Renal Acidification Defects: Real-World Evidence of Metabolic Dysfunction in Dysglycemia
04:41PM - 04:48PM
Prevalence of Sarcopenic Obesity in Adults with BMI ≥23 kg/m² and Its Association with Cardiometabolic and Lifestyle Factors: A DEXA-Based Analysis
04:55PM - 05:00PM
Wrap Up & Conclusion
